Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
about
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cellsNew perspectives on the role of vitiligo in immune responses to melanomaImmune modulation of the tumor microenvironment for enhancing cancer immunotherapyAntitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in MiceIdentification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencingRoutes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in miceTargeting the tumor microenvironment to enhance antitumor immune responsesExploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersToll-like receptors as novel therapeutic targets for ovarian cancer.Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in miPotentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor modelsTargeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.Neuropilin 1: function and therapeutic potential in cancer.Intratumoral immunotherapy for melanoma.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.In situ vaccination for the treatment of cancer.Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.Innate immune mediators in cancer: between defense and resistance.Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally.The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiesNF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses.Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2(180-188)-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2(180-188) peptides.Activation of viral defense signaling in cancer
P2860
Q24601213-A25B6872-176D-4E46-844B-6B768449E558Q26996799-ABDA4940-AA33-4942-8785-15C2356FF5ABQ27002646-F2578125-52A5-42F0-B744-12BF363F309EQ27318732-55E3C249-7E24-4BF6-B055-A13D0D764246Q27334215-616F7CF4-9BAB-41A0-A644-228FED34D00AQ27335400-736B6E67-EAAA-470E-86C4-C82F3CFDC21DQ35176307-4DA5CCFC-5086-49BA-8436-2C954008BD06Q35738744-33373D41-DD4C-44B3-AFC6-CD216CE8C818Q35864309-73134ECE-4D16-4E41-8849-FCC7732DC078Q36054193-C2FDE875-5528-4F76-A751-EE778E546FBAQ36487567-0C6E7D6F-D292-4C20-BE49-FDE185C87641Q36646698-1D268B5B-B02D-4C3B-93F3-E7A3D39F80A1Q36664213-B51D1421-76B8-44A4-99B6-AE53064E5229Q36827406-FEFA7B11-1048-4E59-915B-17D9E8D149DFQ37184436-3F098033-E437-4613-843F-EBCF23DA0A37Q38165001-8DF5D6FE-EE7B-4069-93E4-766CA9B92A32Q38518518-2395AE7E-B6D3-4F2A-B999-F03DA973DE8AQ38657642-390DF8EF-9F49-4D75-825D-58C90BA5C4AEQ38727470-C6767FB3-C17A-4A7A-AFEF-06263E6997A0Q38781955-CB20E3F7-817C-4CF3-BEF7-B755D936EABCQ38991015-3E55CAC9-5F43-4E5B-9C89-A0FDD62FAD38Q39043844-758DAB66-AE66-4F48-B830-ECB1C0C77B75Q41442041-3BF090D7-E233-4A11-9763-69D5D0B0CE99Q45723785-22400909-925F-4BED-90DE-0F69FB060CDEQ50964057-B40142B1-A528-4378-98C6-B88E4EEACF5EQ58695217-06A61FC2-35D2-43EE-9924-1E9A9774A1DE
P2860
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Adoptive immunotherapy combine ...... s established melanoma in mice
@ast
Adoptive immunotherapy combine ...... s established melanoma in mice
@en
type
label
Adoptive immunotherapy combine ...... s established melanoma in mice
@ast
Adoptive immunotherapy combine ...... s established melanoma in mice
@en
prefLabel
Adoptive immunotherapy combine ...... s established melanoma in mice
@ast
Adoptive immunotherapy combine ...... s established melanoma in mice
@en
P2093
P2860
P50
P1476
Adoptive immunotherapy combine ...... s established melanoma in mice
@en
P2093
Chris J Clarke
Christel Devaud
Hollie J Pegram
Jennifer A Westwood
Liza B John
Sally M Amos
P2860
P2888
P304
P356
10.1007/S00262-011-0984-8
P577
2011-02-16T00:00:00Z